Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-022331
Filing Date
2020-08-14
Accepted
2020-08-14 17:12:22
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_citiuspharma.htm 10-Q 461718
2 EMPLOYMENT AGREEMENT, EFFECTIVE AS OF JULY 14, 2020, BETWEEN CITIUS PHARMACEUTIC f10q0620ex10-3_citiuspharma.htm EX-10.3 55364
3 CERTIFICATION f10q0620ex31-1_citiuspharma.htm EX-31.1 9643
4 CERTIFICATION f10q0620ex31-2_citiuspharma.htm EX-31.2 9870
5 CERTIFICATION f10q0620ex32-1_citiuspharma.htm EX-32.1 6141
  Complete submission text file 0001213900-20-022331.txt   3180104

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ctxr-20200630.xml EX-101.INS 476283
7 XBRL SCHEMA FILE ctxr-20200630.xsd EX-101.SCH 46765
8 XBRL CALCULATION FILE ctxr-20200630_cal.xml EX-101.CAL 40226
9 XBRL DEFINITION FILE ctxr-20200630_def.xml EX-101.DEF 146344
10 XBRL LABEL FILE ctxr-20200630_lab.xml EX-101.LAB 299309
11 XBRL PRESENTATION FILE ctxr-20200630_pre.xml EX-101.PRE 228947
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 201106527
SIC: 2834 Pharmaceutical Preparations